XML 15 R5.htm IDEA: XBRL DOCUMENT v3.26.3
Condensed Consolidated Statements of Changes in Stockholders Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
ATM
ATM
Common Stock
ATM
Additional Paid-in Capital
Public offering
Public offering
Common Stock
Public offering
Additional Paid-in Capital
Balance at Dec. 31, 2024 $ 181,165 $ 6 $ 696,872 $ 57 $ (515,770)            
Balance (in shares) at Dec. 31, 2024   64,460,829                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation expense 5,703   5,703                
Issuance of common stock                 $ 161,745 $ 3 $ 161,742
Issuance of common stock (in shares)                   22,258,064  
Exercise of stock options 213   213                
Exercise of stock options (in shares)   236,962                  
Unrealized gain (loss) on marketable securities (60)     (60)              
Net loss (41,640)       (41,640)            
Balance at Mar. 31, 2025 307,126 $ 9 864,530 (3) (557,410)            
Balance (in shares) at Mar. 31, 2025   86,955,855                  
Balance at Dec. 31, 2024 181,165 $ 6 696,872 57 (515,770)            
Balance (in shares) at Dec. 31, 2024   64,460,829                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (142,494)                    
Balance at Sep. 30, 2025 263,919 $ 9 922,174   (658,264)            
Balance (in shares) at Sep. 30, 2025   91,706,948                  
Balance at Dec. 31, 2024 181,165 $ 6 696,872 57 (515,770)            
Balance (in shares) at Dec. 31, 2024   64,460,829                  
Balance at Dec. 31, 2025 634,343 $ 11 1,362,496   (728,164)            
Balance (in shares) at Dec. 31, 2025   113,133,199                  
Balance at Mar. 31, 2025 307,126 $ 9 864,530 (3) (557,410)            
Balance (in shares) at Mar. 31, 2025   86,955,855                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation expense 5,347   5,347                
Exercise of stock options 215   215                
Exercise of stock options (in shares)   56,980                  
Unrealized gain (loss) on marketable securities (21)     (21)              
Net loss (43,397)       (43,397)            
Balance at Jun. 30, 2025 269,270 $ 9 870,092 (24) (600,807)            
Balance (in shares) at Jun. 30, 2025   87,012,835                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation expense 6,747   6,747                
Issuance of common stock           $ 44,924   $ 44,924      
Issuance of common stock (in shares)             4,625,156        
Exercise of stock options 411   411                
Exercise of stock options (in shares)   68,957                  
Unrealized gain (loss) on marketable securities 24     24              
Net loss (57,457)       (57,457)            
Balance at Sep. 30, 2025 263,919 $ 9 922,174   (658,264)            
Balance (in shares) at Sep. 30, 2025   91,706,948                  
Balance at Dec. 31, 2025 634,343 $ 11 1,362,496   (728,164)            
Balance (in shares) at Dec. 31, 2025   113,133,199                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation expense 7,953   7,953                
Exercise of stock options 229   229                
Exercise of stock options (in shares)   38,197                  
Net loss (53,839)       (53,839)            
Balance at Mar. 31, 2026 588,686 $ 11 1,370,678   (782,003)            
Balance (in shares) at Mar. 31, 2026   113,171,396                  
Balance at Dec. 31, 2025 $ 634,343 $ 11 1,362,496   (728,164)            
Balance (in shares) at Dec. 31, 2025   113,133,199                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock (in shares)           0          
Exercise of stock options (in shares) 514,257                    
Net loss $ (212,749)                    
Balance at Sep. 30, 2026 454,303 $ 11 1,395,672 (467) (940,913)            
Balance (in shares) at Sep. 30, 2026   113,647,456                  
Balance at Mar. 31, 2026 588,686 $ 11 1,370,678   (782,003)            
Balance (in shares) at Mar. 31, 2026   113,171,396                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation expense 8,799   8,799                
Exercise of stock options 1,058   1,058                
Exercise of stock options (in shares)   227,806                  
Unrealized gain (loss) on marketable securities (333)     (333)              
Net loss (73,127)       (73,127)            
Balance at Jun. 30, 2026 525,083 $ 11 1,380,535 (333) (855,130)            
Balance (in shares) at Jun. 30, 2026   113,399,202                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation expense 12,761   12,761                
Exercise of stock options 2,376   2,376                
Exercise of stock options (in shares)   248,254                  
Unrealized gain (loss) on marketable securities (134)     (134)              
Net loss (85,783)       (85,783)            
Balance at Sep. 30, 2026 $ 454,303 $ 11 $ 1,395,672 $ (467) $ (940,913)            
Balance (in shares) at Sep. 30, 2026   113,647,456